메뉴 건너뛰기




Volumn 56, Issue SUPPL. 1, 2011, Pages

Patient perspectives on buprenorphine/naloxone treatment in the context of HIV care

Author keywords

buprenorphine naloxone; heroin dependence; HIV AIDS; opioid treatment; patient satisfaction; qualitative research; substance use treatment

Indexed keywords

ANTIRETROVIRUS AGENT; BUPRENORPHINE PLUS NALOXONE; METHADONE; OPIATE;

EID: 79951782715     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAI.0b013e3182097561     Document Type: Article
Times cited : (32)

References (24)
  • 2
    • 33845403539 scopus 로고    scopus 로고
    • The potential role of buprenorphine in the treatment of opioid dependence in HIV-infected individuals and in HIV infection prevention
    • DOI 10.1086/508181
    • Altice FL, Sullivan LE, Smith-Rohrberg D, et al. The potential role of buprenorphine in the treatment of opioid dependence in HIV-infected individuals and in HIV infection prevention. Clin Infect Dis. 2006; 43(Suppl 4):S178-S183. (Pubitemid 44901885)
    • (2006) Clinical Infectious Diseases , vol.43 , Issue.SUPPL. 4
    • Altice, F.L.1    Sullivan, L.E.2    Smith-Rohrberg, D.3    Basu, S.4    Stancliff, S.5    Eldred, L.6
  • 4
    • 23744500413 scopus 로고    scopus 로고
    • Barriers and facilitators to primary care or human immunodeficiency virus clinics providing methadone or buprenorphine for the management of opioid dependence
    • DOI 10.1001/archinte.165.15.1769
    • Turner BJ, Laine C, Lin YT, et al. Barriers and facilitators to primary care or human immunodeficiency virus clinics providing methadone or buprenorphine for the management of opioid dependence. Arch Intern Med. 2005;165:1769-1776. (Pubitemid 41138966)
    • (2005) Archives of Internal Medicine , vol.165 , Issue.15 , pp. 1769-1776
    • Turner, B.J.1    Laine, C.2    Lin, Y.-T.3    Lynch, K.4
  • 5
    • 24644476431 scopus 로고    scopus 로고
    • Buprenorphine: Its role in preventing HIV transmission and improving the care of HIV-infected patients with opioid dependence
    • DOI 10.1086/432888
    • Sullivan LE, Fiellin DA. Buprenorphine: its role in preventing HIV transmission and improving the care of HIV-infected patients with opioid dependence. Clin Infect Dis. 2005;41:891-896. (Pubitemid 41266759)
    • (2005) Clinical Infectious Diseases , vol.41 , Issue.6 , pp. 891-896
    • Sullivan, L.E.1    Fiellin, D.A.2
  • 6
    • 33751298756 scopus 로고    scopus 로고
    • Training HIV physicians to prescribe buprenorphine for opioid dependence
    • DOI 10.1300/J465v27n03-03
    • Sullivan LE, Tetrault J, Bangalore D, et al. Training HIV physicians to prescribe buprenorphine for opioid dependence. Subst Abus. 2006;27: 13-18. (Pubitemid 44800477)
    • (2006) Substance Abuse , vol.27 , Issue.3 , pp. 13-18
    • Sullivan, L.E.1    Tetrault, J.2    Bangalore, D.3    Fiellin, D.A.4
  • 7
    • 61349160477 scopus 로고    scopus 로고
    • Factors affecting willingness to provide buprenorphine treatment
    • Netherland J, Botsko M, Egan JE, et al. Factors affecting willingness to provide buprenorphine treatment. J Subst Abuse Treat. 2009;36:244-251.
    • (2009) J Subst Abuse Treat , vol.36 , pp. 244-251
    • Netherland, J.1    Botsko, M.2    Egan, J.E.3
  • 9
    • 0842288228 scopus 로고    scopus 로고
    • Guideline development for office-based pharmacotherapies for opioid dependence
    • DOI 10.1300/J069v22n04-09
    • Fiellin DA, Barthwell AG. Guideline development for office-based pharmacotherapies for opioid dependence. J Addict Dis. 2003;22: 109-120. (Pubitemid 38174759)
    • (2003) Journal of Addictive Diseases , vol.22 , Issue.4 , pp. 109-120
    • Fiellin, D.A.1    Barthwell, A.G.2
  • 10
    • 33646561547 scopus 로고    scopus 로고
    • Attending physicians' and residents' attitudes and beliefs about prescribing buprenorphine at an urban teaching hospital
    • Cunningham CO, Sohler NL, McCoy K, et al. Attending physicians' and residents' attitudes and beliefs about prescribing buprenorphine at an urban teaching hospital. Fam Med. 2006;38:336-340. (Pubitemid 43723598)
    • (2006) Family Medicine , vol.38 , Issue.5 , pp. 336-340
    • Cunningham, C.O.1    Sohler, N.L.2    McCoy, K.3    Kunins, H.V.4
  • 11
    • 79951798891 scopus 로고    scopus 로고
    • Links between primary care, addiction services may help treatment
    • Accessed December 1, 2009
    • Elliot V. Links between primary care, addiction services may help treatment. American Medical News. Available at: www.amednews.com. 2001. Accessed December 1, 2009.
    • (2001) American Medical News
    • Elliot, V.1
  • 15
    • 79951801129 scopus 로고    scopus 로고
    • Patients' reasons for choosing office-based buprenorphine: Preference for patient-centered care
    • Korthuis PT, Gregg J, Rogers WE, et al. Patients' reasons for choosing office-based buprenorphine: preference for patient-centered care. J Addict Med. 2010;4:204-210.
    • (2010) J Addict Med , vol.4 , pp. 204-210
    • Korthuis, P.T.1    Gregg, J.2    Rogers, W.E.3
  • 16
    • 67349190259 scopus 로고    scopus 로고
    • Factors associated with the prescribing of buprenorphine or methadone for treatment of opiate dependence
    • Ridge G, Gossop M, Lintzeris N, et al. Factors associated with the prescribing of buprenorphine or methadone for treatment of opiate dependence. J Subst Abuse Treat. 2009;37:95-100.
    • (2009) J Subst Abuse Treat , vol.37 , pp. 95-100
    • Ridge, G.1    Gossop, M.2    Lintzeris, N.3
  • 18
    • 0003152560 scopus 로고
    • Qualitative methods in drug abuse and HIV research
    • US department of Health and Human Services, National Institutes of Health, Rockville, MD
    • Lambert EY, Ashery RS, Needle RH. Qualitative methods in drug abuse and HIV research. NIDA Research Monograph 157. 1995. US department of Health and Human Services, National Institutes of Health, Rockville, MD.
    • (1995) NIDA Research Monograph 157
    • Lambert, E.Y.1    Ashery, R.S.2    Needle, R.H.3
  • 19
    • 79951781216 scopus 로고    scopus 로고
    • A model federal collaborative to increase patient access to buprenorphine treatment in HIV primary care
    • Cheever LW, Kresina TF, Cajina A, et al. A model federal collaborative to increase patient access to buprenorphine treatment in HIV primary care. J Acquir Immune Defic Syndr. 2011;56(Suppl 1):S3-S6.
    • (2011) J Acquir Immune Defic Syndr , vol.56 , Issue.SUPPL. 1
    • Cheever, L.W.1    Kresina, T.F.2    Cajina, A.3
  • 20
    • 79951793012 scopus 로고    scopus 로고
    • A multi-site evaluation of integrated buprenorphine/naloxone and HIV treatment: Overview of the BHIVES collaborative
    • Weiss L, Egan JE, Botsko M, et al. A multi-site evaluation of integrated buprenorphine/naloxone and HIV treatment: overview of the BHIVES collaborative. J Acquir Immune Defic Syndr. 2009;36:244-251.
    • (2009) J Acquir Immune Defic Syndr , vol.36 , pp. 244-251
    • Weiss, L.1    Egan, J.E.2    Botsko, M.3
  • 23
    • 79951777614 scopus 로고    scopus 로고
    • Improved quality of life for opioid-dependent patients receiving buprenorphine treatment in HIV clinics
    • Korthuis PT, Tozzi MJ, Nandi V. Improved quality of life for opioid-dependent patients receiving buprenorphine treatment in HIV clinics. J Acquir Immune Defic Syndr. 2011;56(Suppl 1):S39-S45.
    • (2011) J Acquir Immune Defic Syndr , vol.56 , Issue.SUPPL. 1
    • Korthuis, P.T.1    Tozzi, M.J.2    Nandi, V.3
  • 24
    • 79951777470 scopus 로고    scopus 로고
    • Drug Addiction Treatment Act of 2000. Public Law 106-310-106th Congress, SEC. 3501. NOTE: 21 USC 801-SEC. 3502. Amendment to Controlled Substances Act; 2000.
    • Drug Addiction Treatment Act of 2000. Public Law 106-310-106th Congress, SEC. 3501. NOTE: 21 USC 801-SEC. 3502. Amendment to Controlled Substances Act; 2000.


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.